Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer

European Journal of Cancer ◽

10.1016/j.ejca.2020.08.020 ◽

2020 ◽

Vol 139 ◽

pp. 119-134

Author(s):

Carmen Salvador-Coloma ◽

Ana Santaballa ◽

Elena Sanmartín ◽

David Calvo ◽

Ana García ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Triple Negative Breast Cancer ◽

Liquid Biopsy ◽

Triple Negative ◽

Response To Neoadjuvant Chemotherapy

Download Full-text

Abstract P3-11-16: Immunosuppressive profiles in liquid biopsy predict response to neoadjuvant chemotherapy in triple negative breast cancer

10.1158/1538-7445.sabcs18-p3-11-16 ◽

2019 ◽

Author(s):

C Salvador-Coloma ◽

J Font De Mora ◽

L Cordón ◽

L Palomar ◽

A Santaballa

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Triple Negative Breast Cancer ◽

Liquid Biopsy ◽

Triple Negative ◽

Response To Neoadjuvant Chemotherapy

Download Full-text

Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancer

Magnetic Resonance Materials in Physics Biology and Medicine ◽

10.1007/s10334-021-00941-0 ◽

2021 ◽

Author(s):

Angeline Nemeth ◽

Pierre Chaudet ◽

Benjamin Leporq ◽

Pierre-Etienne Heudel ◽

Fanny Barabas ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Pathological Complete Response ◽

Complete Response ◽

Response To Neoadjuvant Chemotherapy

Download Full-text

Predictive Clinicopathologic and Dynamic Contrast-Enhanced MRI Findings for Tumor Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

American Journal of Roentgenology ◽

10.2214/ajr.16.17125 ◽

2017 ◽

Vol 208 (6) ◽

pp. W225-W230 ◽

Cited By ~ 11

Author(s):

Hye-Joung Eom ◽

Joo Hee Cha ◽

Woo Jung Choi ◽

Eun Young Chae ◽

Hee Jung Shin ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Tumor Response ◽

Mri Findings ◽

Dynamic Contrast Enhanced ◽

Contrast Enhanced ◽

Response To Neoadjuvant Chemotherapy ◽

Contrast Enhanced Mri

Download Full-text

Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients With Triple Negative Breast Cancer?

Journal of Surgical Research ◽

10.1016/j.jss.2011.11.891 ◽

2012 ◽

Vol 172 (2) ◽

pp. 337

Author(s):

J. Atkins ◽

A. Cyr ◽

C.M. Appleton ◽

C.S. Fisher ◽

J.A. Margenthaler

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Imaging Modality ◽

Prediction Of Response ◽

Response To Neoadjuvant Chemotherapy

Download Full-text

A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients

Clinical Epigenetics ◽

10.1186/s13148-019-0626-0 ◽

2019 ◽

Vol 11 (1) ◽

Cited By ~ 13

Author(s):

Begoña Pineda ◽

Angel Diaz-Lagares ◽

José Alejandro Pérez-Fidalgo ◽

Octavio Burgués ◽

Inés González-Barrallo ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Breast Cancer Patients ◽

Prediction Of Response ◽

Response To Neoadjuvant Chemotherapy

Download Full-text

Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer?

Journal of Oncology ◽

10.1155/2013/964863 ◽

2013 ◽

Vol 2013 ◽

pp. 1-7 ◽

Cited By ~ 13

Author(s):

Jordan J. Atkins ◽

Catherine M. Appleton ◽

Carla S. Fisher ◽

Feng Gao ◽

Julie A. Margenthaler

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Imaging Modality ◽

Prediction Of Response ◽

Response To Neoadjuvant Chemotherapy

Download Full-text

Abstract 1792: Immune system pathway activation for prediction of the response to neoadjuvant chemotherapy in triple-negative breast cancer

10.1158/1538-7445.am2017-1792 ◽

2017 ◽

Author(s):

Takeshi Sawada ◽

Riet Hilhorst ◽

Savithri Rangarajan ◽

Masayuki Yoshida ◽

Kenji Tamura ◽

...

Keyword(s):

Breast Cancer ◽

Immune System ◽

Neoadjuvant Chemotherapy ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Pathway Activation ◽

Response To Neoadjuvant Chemotherapy

Download Full-text

Matrix-producing Carcinoma as an Aggressive Triple-negative Breast Cancer: Clinicopathological Features and Response to Neoadjuvant Chemotherapy

Anticancer Research ◽

10.21873/anticanres.13536 ◽

2019 ◽

Vol 39 (7) ◽

pp. 3863-3869

Author(s):

KAZUHIRO SHIMADA ◽

TAKASHI ISHIKAWA ◽

AKIMITSU YAMADA ◽

SADATOSHI SUGAE ◽

KAZUTAKA NARUI ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Clinicopathological Features ◽

Response To Neoadjuvant Chemotherapy

Download Full-text

Incidence of PI3K pathway aberrations and their impact on response to neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC) subtypes.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.588 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 588-588

Author(s):

Reva K Basho ◽

Alex Trevarton ◽

Kenneth R. Hess ◽

Chunxiao Fu ◽

Rosanna Lau ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Pi3k Pathway ◽

Response To Neoadjuvant Chemotherapy

Download Full-text

Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer

European Journal of Nuclear Medicine and Molecular Imaging ◽

10.1007/s00259-021-05542-6 ◽

2021 ◽

Author(s):

Sudipta Roy ◽

Timothy D. Whitehead ◽

Shunqiang Li ◽

Foluso O. Ademuyiwa ◽

Richard L. Wahl ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Triple Negative Breast Cancer ◽

Fdg Pet ◽

Triple Negative ◽

Response To Neoadjuvant Chemotherapy

Download Full-text